Status:

RECRUITING

HYEEG Discourse in Psychosis: A Neurobehavioural Study

Lead Sponsor:

Douglas Mental Health University Institute

Conditions:

Psychosis

Schizophrenia Disorders

Eligibility:

All Genders

18-60 years

Brief Summary

This multimodal study explores the mechanisms underlying social dysfunction in individuals with schizophrenia. It focuses on the relationship between disorganized communication and social interaction,...

Detailed Description

INTRODUCTION Schizophrenia, often associated with psychosis, is a severe mental disorder that profoundly impacts individuals, families, and society, diminishing quality of life and well-being globall...

Eligibility Criteria

Inclusion

  • English or French-speaking participants (as dyads matched for language preference).
  • Ages 18-60 years.
  • Patients meeting the operational criteria for schizophrenia or schizoaffective illness as previously diagnosed by their treating psychiatrist, based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 criteria (Zipursky et al., 2020).
  • Patients with less than 5 years of illness onset, based on the time of starting treatment with antipsychotic medication.

Exclusion

  • Participants should not have a primary diagnosis of Alcohol or Drug abuse or addiction (however, co-morbid substance abuse with a primary diagnosis of psychotic disorder is not an exclusion criterion).
  • Participants should not have a severe medical disorder that would explain psychotic symptoms.
  • Participants should not have a past or current history of a primary neurological disorder that can affect speech output
  • Participants with IQ below 70 or a concurrent pervasive developmental disorder (e.g., autism) will also be excluded.

Key Trial Info

Start Date :

January 16 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT06978803

Start Date

January 16 2024

End Date

December 31 2026

Last Update

May 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Douglas Mental Health University Institute

Montreal, Quebec, Canada, H4H 1R3